Reduced glutamine levels, potentially linked to a glutamine synthetase deficit, impair the glutamate–glutamine cycle, as observed in patients with status epilepticus (Hanin et al., 2024) and in a rat model of epilepsy (Swamy et al., 2011). The gene discussed is GLUL; the disease is epilepsy.